[Prospective evaluation of radiation-induced thyroid disorders after breast and supraclavicular irradiation].
Fiche publication
Date publication
mai 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Dr DEBREUVE-THERESETTE Adeline
Tous les auteurs :
Ettalhaoui L, Debreuve-Théresette A, Nguyen TD, Zalzali M, Antoni D, Guilbert P
Lien Pubmed
Résumé
The thyroid is an endocrine gland playing a major role in metabolism and development by the secretion of T4 and T3 thyroid hormones. Due to its anatomical position, it is often included in the target volume for the irradiation of certain tumours and thus receives significant doses (10 to 80Gy). The treatment of breast cancer requires in most cases a breast irradiation associated or not with a lymph node irradiation. The aim of our study was to investigate prospectively the frequency of thyroid disorders in patients with breast cancer treated by radiation, with or without irradiation of the supra- and subclavicular lymph nodes.
Mots clés
Breast tumour, Maladies de la thyroïde, Radiotherapy, Radiothérapie, Thyroid, Thyroid disease, Thyroïde, Tumeurs du sein
Référence
Cancer Radiother. 2023 05 11;: